-Michael D Feldman Researcher Activity Profile

Research Author Detailed Information 

Michael D Feldman Publication Rate By Year

Michael D Feldman has published 5 paper(s) in 1949, 1 paper(s) in 2004, 7 paper(s) in 2006, 22 paper(s) in 2007, 3 paper(s) in 2008, for a total of 38 research publications in total.

Michael D Md Feldman Author Information

LAST NAME: feldman

FIRST NAME: Michael D

INITIALS: md

AFFILIATION:

Papers

Michael D Feldman's Publication Record

1. Bone morphogenetic proteins are expressed by both bone-forming and non-bone-forming lesions. Year Published: 2004
Department of Pathology, Temple University Hospital, Philadelphia, Pa 19140, USA. khuranjs@tuhs.temple.edu
2. Detection of vulnerable plaque in a murine model of atherosclerosis with optical coherence tomography. Year Published: 2006
Division of Cardiology, Department of Medicine, University of Texas Health Science Center in San Antonio, San Antonio, Texas 78229-3900, USA.
3. The impact of HER-2 status on local recurrence in women with stage I-II breast cancer treated with breast-conserving therapy. Year Published: 2006
Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, USA. HarrisE@moffitt.usf.edu
4. Inhibition of tumor endothelial ERK activation, angiogenesis, and tumor growth by sorafenib (BAY43-9006). Year Published: 2006
Biomedical Graduate Program, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
5. Barriers to psychotherapy among depressed and nondepressed primary care patients. Year Published: 2006
University of California, Veterans Administration Medical Center, San Francisco, California, USA. david.mohr@ucsf.edu
6. Do patient requests for antidepressants enhance or hinder physicians' evaluation of depression? A randomized controlled trial. Year Published: 2006
Division of General Internal Medicine, Department of Medicine, University of California, San Francisco, USA. mfeldman@medicine.ucsf.edu
7. Interleukin-18 knockout mice display maladaptive cardiac hypertrophy in response to pressure overload. Year Published: 2007
South Texas Veterans Health Care System, San Antonio, TX, USA.
8. Downregulation of Rap1GAP contributes to Ras transformation. Year Published: 2007
Department of Pharmacology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104-6061, USA.
9. Dose-dependent effects of topical tobramycin in an animal model of Pseudomonas sinusitis. Year Published: 2007
Department of Otorhinolaryngology, Division of Rhinology, University of Pennsylvania, Philadelphia 19104, USA.
10. Let's not talk about it: suicide inquiry in primary care. Year Published: 2007
Division of General Internal Medicine, Department of Medicine, University of California, San Francisco, Calif, USA.
11. Malingering in the medical setting. Year Published: 2007
University of California, Davis School of Medicine, Department of Psychiatry and Behavioral Sciences, Division of Psychiatry and the Law, 2230 Stockton Blvd, 2nd Floor, Sacramento, CA 95817, USA. bemcdermott@ucdavis.edu
12. Real time Pressure-Volume loops in mice using complex admittance: measurement and implications. Year Published: 2007
Dept. of Biomed. Eng., Texas Univ., Austin, TX.
13. Telomerase-specific T-cell immunity in breast cancer: effect of vaccination on tumor immunosurveillance. Year Published: 2007
Abramson Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.
14. Beyond Munchausen syndrome by proxy. Year Published: 2007
15. High throughput analysis of breast cancer specimens on the grid. Year Published: 2007
Dept. of Electrical and Computer Eng., Rutgers Univ., Piscataway, NJ 08544, USA.
16. IL-17 stimulates MMP-1 expression in primary human cardiac fibroblasts via p38 MAPK- and ERK1/2-dependent C/EBP- , NF-{kappa}B, and AP-1 activation. Year Published: 2007
Medicine/Cardiology, The Univ. of Texas Health Science Center, 7703 Floyd Curl Dr., San Antonio, TX 78229-3900. chandraseka@uthscsa.edu).
17. Beyond Munchausen syndrome by proxy. Year Published: 2007
18. Malingering in the medical setting. Year Published: 2007
University of California, Davis School of Medicine, Department of Psychiatry and Behavioral Sciences, Division of Psychiatry and the Law, 2230 Stockton Blvd, 2nd Floor, Sacramento, CA 95817, USA. bemcdermott@ucdavis.edu
19. Full-field digital mammography compared with screen-film mammography in the detection of breast cancer: rays of light through DMIST or more fog? Year Published: 2007
Division of General Internal Medicine, Department of Medicine, University of California, 1701 Divisadero Street, Suite 554, San Francisco, CA, 94143-1732, USA, jtice@medicine.ucsf.edu.
20. Contact dermatitis from the topical application of streptomycin ointment; report of a case. Year Published: 1949
21. Sensitization to penicillin; the types of reactions; therapy and prevention. Year Published: 1949
22. Human infestation with scabies of monkeys. Year Published: 1949
23. The impact of HER-2 status on local recurrence in women with stage I-II breast cancer treated with breast-conserving therapy. Year Published: 2006
Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, USA. HarrisE@moffitt.usf.edu
24. Contact dermatitis from the topical application of streptomycin ointment; report of a case. Year Published: 1949
25. High throughput analysis of breast cancer specimens on the grid. Year Published: 2007
Dept. of Electrical and Computer Eng., Rutgers Univ., Piscataway, NJ 08544, USA.
26. Who is responsible for evaluating the safety and effectiveness of medical devices? The role of independent technology assessment. Year Published: 2007
Division of General Internal Medicine, Department of Medicine, University of California, San Francisco, San Francisco, CA 94143-0320, USA. mfeldman@medicine.ucsf.edu
27. Antitumor effect of the angiogenesis inhibitor bevacizumab is dependent on susceptibility of tumors to hypoxia-induced apoptosis. Year Published: 2008
Abramson Cancer Center, University of Pennsylvania, 1020 BRB II/III, 421 Curie Blvd, Philadelphia, PA 19104, United States.
28. The impact of HER-2 status on local recurrence in women with stage I-II breast cancer treated with breast-conserving therapy. Year Published: 2006
Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, USA. HarrisE@moffitt.usf.edu
29. Contact dermatitis from the topical application of streptomycin ointment; report of a case. Year Published: 1949
30. IL-17 stimulates MMP-1 expression in primary human cardiac fibroblasts via p38 MAPK- and ERK1/2-dependent C/EBP- , NF-kappaB, and AP-1 activation. Year Published: 2007
Department of Veterans Affairs South Texas Veterans Health Care System, The University of Texas Health Science Center, 7703 Floyd Curl Drive, San Antonio, TX 78229-3900, USA.
31. Downregulation of Rap1GAP contributes to Ras transformation. Year Published: 2007
Department of Pharmacology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104-6061, USA.
32. IL-17 stimulates MMP-1 expression in primary human cardiac fibroblasts via p38 MAPK- and ERK1/2-dependent C/EBP-beta , NF-kappaB, and AP-1 activation. Year Published: 2007
Department of Veterans Affairs South Texas Veterans Health Care System, The University of Texas Health Science Center, 7703 Floyd Curl Drive, San Antonio, TX 78229-3900, USA.
33. Psychiatric and behavioral correlates of factitious blindness. Year Published: 2008
University of Alabama, Tuscaloosa, Birmingham, AL 35243-5351, USA.
34. Introduction: new medical device technologies. Year Published: 2007
Division of General Internal Medicine, Department of Medicine, University of California, San Francisco, CA, USA, jtice@medicine.ucsf.edu.
35. Who is responsible for evaluating the safety and effectiveness of medical devices? The role of independent technology assessment. Year Published: 2007
Division of General Internal Medicine, Department of Medicine, University of California, San Francisco, San Francisco, CA 94143-0320, USA. mfeldman@medicine.ucsf.edu
36. Real time pressure-volume loops in mice using complex admittance: measurement and implications. Year Published: 2007
Dept. of Biomed. Eng., Texas Univ., Austin, TX 78712, USA. kottam@mail.utexas.edu
37. Antitumor effect of the angiogenesis inhibitor bevacizumab is dependent on susceptibility of tumors to hypoxia-induced apoptosis. Year Published: 2008
Abramson Cancer Center, University of Pennsylvania, 1020 BRB II/III, 421 Curie Blvd., Philadelphia, PA 19104, USA. selvan@pharm.med.upenn.edu
38. Real time pressure-volume loops in mice using complex admittance: measurement and implications. Year Published: 2007
Dept. of Biomed. Eng., Texas Univ., Austin, TX 78712, USA. kottam@mail.utexas.edu